objective

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

3 weeks ago

Hibiki Path Advisors has Requested the Board of Directors of Tomoe Corporation (1921) for a Complete Overhaul of the Medium-Term Management Plan and Establishment of a Special Committee

TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors (“Hibiki” or “We”) is a Singapore-based investment management firm that manages capital for clients in Japan…

1 month ago

VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan

LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”) announced today that its…

4 months ago

“AI and the Art Market” by Arte, with Artprice by Artmarket and analysis by Perplexity.AI Labs

PARIS, June 16, 2025 /PRNewswire/ -- This Sunday, June 15th, 2025, the Franco-German TV channel Arte broadcast the documentary "AI…

5 months ago